Abbott fails US AIDS activists' scorecard
This article was originally published in Scrip
Executive Summary
Abbott Laboratories has received the lowest grade out of nine large pharmaceutical firms for its HIV efforts in drug development, access to drugs, pricing, community relations and marketing practices. Merck & Co and Tibotec received the highest grade.